[In-vitro synergism between beta-lactam antibiotics and aminoglycoside antibiotics in Pseudomonas, Proteus and Klebsiella (proceedings)].
D000617:Aminoglycosides / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004357:Drug Synergism; D007709:Klebsiella / Q000187:drug effects*; D008826:Microbial Sensitivity Tests; D011511:Proteus / Q000187:drug effects*; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D047090:beta-Lactams / Q000494:pharmacology*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D047090:beta-Lactams
Der In-vitro-Synergismus zwischen beta-Laktam-Antibiotika und Aminoglykosid-Antibiotika bei Pseudomonas, Proteus und Klebsiella